CartiHeal secures $5M in venture funding CartiHeal.

Histology performed by NAMSA has demonstrated that the Agili-CTM regenerates true hyaline cartilage after six months in preclinical studies. The ability to regenerate hyaline cartilage, instead of ‘hyaline-like cartilage, within a stage procedure, without the use of exogenous cells or growth factors, is considered the ULTIMATE GOAL in cartilage repair. The Agili-CTM can be CE marked and the company happens to be running post-marketing clinical studies at leading centers in Europe and Israel. Related StoriesImproved results yielded from new ChIP-seq protocolLiposomal sizing and the Coulter basic principle: an interview with Professor Melvin E. KlegermanLinkam stages used in the Wolfson Bioimaging Facility at the University of Bristol within the endocytic sorting research of Dr Paul VerkadeThere are approximately 1.2 million cartilage repair methods performed world-wide annually, according to BioMedGPS.A-HeFT represents a substantial step of progress in addressing these disparities. Related StoriesMeta-analysis helps that intake of tree nuts lowers threat of cardiovascular diseaseLow degrees of stem cell aspect associated with increased threat of cardiovascular diseaseBrain wellness: how will you decrease cognitive decline? An interview with Heather Snyder, Ph.D.Heart failing, or end-stage coronary disease, affects five million People in america approximately. There is absolutely no cure because of this disease, and a lot more than 50 % of sufferers die within five years of medical diagnosis.